CHEK - CONSENSUS CO - Check-Cap Ltd.

This daily price chart for Check-Cap Ltd. (CHEK) captures the value at . The business is implementing C-Scan, a capsule for the comfortable detection of intestinal polyps using X-ray and software. The team brings together biomedical specialists and laboratory technicians attracted by complex R&D cases and stock options. The company's resilience to external crises is ensured by the demand for medtech, while growth depends on commercialization and testing.

The consensus forecast aggregates expert expectations regarding the asset's fair value, serving as an indicator of market equilibrium and the level of confidence in the business model. The trend in the consensus share price discounts future cash flows, which for Check-Cap Ltd. (CHEK) depends directly on the results of the capsule system's clinical trials and the subsequent recognition of the method by insurance companies.